- What the MGP Exam Actually Tests
- Registration, Fees, and Test-Day Logistics
- The 17 Domains: Where to Focus Your Study Time
- Eligibility Checkpoints Before You Can Sit for MGP
- Building a Domain-Weighted Study Timeline
- Understanding the Passing Standard and Recent Results
- After You Pass: Maintaining Certification
- Common First-Attempt Mistakes to Avoid
- Frequently Asked Questions
- The 2026 MGP exam has 245 questions across six sections in a single in-person Pearson VUE sitting.
- Solid Tumors (11%), Inherited Diseases (10%), and Hematopathology (9%) are the three highest-weighted of the 17 domains.
- The 2026 initial application/examination fee is USD 2,100, including a nonrefundable USD 200 administrative fee.
- ABPath reported 45 of 49 first-time examinees passed in 2025 (92%), against a scaled passing score of 500.
What the MGP Exam Actually Tests
Molecular Genetic Pathology (MGP) certification is a joint subspecialty credential administered through the American Board of Pathology (ABPath) in collaboration with the American Board of Medical Genetics and Genomics (ABMGG). This guide focuses specifically on the initial physician MGP examination pursued through the ABPath application route - not the separate Laboratory Genetics and Genomics certification, which follows a different pathway and eligibility structure. If you have landed here after searching for background on the credential itself, our companion pieces on What Is MGP? and MGP Certification cover the foundational definitions before you dive into exam prep.
The 2026 exam is a computer-based, single-best-answer multiple-choice examination that also incorporates written/practical material - meaning many items require interpreting real laboratory artifacts rather than recalling isolated facts. Expect to work through sequence traces, microarray plots, karyotypes, pedigrees, and quality-control scenarios embedded directly into question stems. This format rewards candidates who have handled these materials in a fellowship laboratory, not just those who have memorized a textbook.
Registration, Fees, and Test-Day Logistics
Unlike remotely proctored exams you may have taken elsewhere, MGP testing happens in person at Pearson VUE Professional Centers. There is no at-home option, so candidates need to plan travel, lodging, and a full testing day around their local center's availability. For a detailed breakdown of deadlines and how the testing calendar is structured, see MGP Exam Dates 2026: Testing Windows, Deadlines & Scheduling.
On the financial side, the 2026 initial application and examination fee is USD 2,100 for the ABPath route, which includes a USD 200 nonrefundable administrative fee. That administrative fee is charged regardless of outcome, so it pays to have your training verification, primary certification status, and supporting documents finalized before you submit - a rejected or incomplete application still costs you that portion. For the complete fee structure and how it compares across pathways, review MGP Certification Cost 2026: Complete Pricing Breakdown.
Key Takeaway
Confirm your ACGME fellowship documentation and primary certification status well before the application deadline - the USD 200 administrative fee is nonrefundable even if your application is ultimately incomplete.
The 17 Domains: Where to Focus Your Study Time
The official 2026 blueprint divides content across 17 domains with approximate weighting. Solid Tumors leads at 11%, followed by Inherited Diseases at 10% and Hematopathology at 9%. Together these three domains represent roughly 30% of the exam, which is why they deserve disproportionate rehearsal time relative to smaller domains like Histocompatibility (2%) or Management and Informatics-General (3%). For a full walkthrough of all 17 areas with study angles for each, see MGP Exam Domains 2026: Complete Guide to All 17 Content Areas.
| Domain | Approximate Weight |
|---|---|
| Solid Tumors | 11% |
| Inherited Diseases | 10% |
| Hematopathology | 9% |
| Normal Structure and Function | 7% |
| Molecular Genetic Principles | 7% |
| Assay Performance and Validation | 7% |
| Quality | 6% |
| Infectious Disease | 6% |
| Techniques and Methods | 5% |
| Ethical, Legal, and Regulatory Issues | 5% |
| Inherited Cancer Syndromes | 5% |
| Pharmacogenetics | 5% |
| Indications for Testing | 4% |
| Identity Testing | 4% |
| Informatics | 4% |
| Management and Informatics-General | 3% |
| Histocompatibility | 2% |
Domain 10: Solid Tumors
As the single largest domain, this section covers actionable mutation testing across common solid tumor types, tumor mutational burden interpretation, and the molecular signatures used for targeted therapy selection.
- Practice distinguishing driver mutations from passenger variants in common tumor panels
- Review companion diagnostic assays tied to FDA-approved targeted therapies
- Study fusion detection methods across lung, thyroid, and soft-tissue tumors
Domain 8: Inherited Diseases
This domain tests pedigree interpretation, inheritance pattern recognition, and correlation between genotype and phenotype in single-gene and complex inherited disorders.
- Master autosomal, X-linked, and mitochondrial inheritance patterns from pedigree data
- Practice reading variant classification (pathogenic, likely pathogenic, VUS) in clinical context
- Distinguish germline findings from incidental somatic changes in the same specimen
Domain 11: Hematopathology
This section blends molecular findings with hematologic malignancy classification, including recurrent translocations, clonality assays, and minimal residual disease monitoring approaches.
- Review recurrent cytogenetic and molecular abnormalities across leukemias and lymphomas
- Understand PCR-based clonality testing and its limitations
- Connect molecular results to WHO classification updates for hematologic neoplasms
A recurring theme across the higher-weighted domains is the need to separate germline versus somatic findings, and infectious-disease versus laboratory-method artifacts, since the exam deliberately tests whether you can classify the source and significance of a molecular result, not just recognize a mutation name.
Eligibility Checkpoints Before You Can Sit for MGP
Before you can register, you need one of two qualifying certification pathways: primary ABPath certification in AP/CP, AP, or CP; or eligible ABMGG physician certification. On top of that, candidates must complete 12 months of ACGME-accredited Molecular Genetic Pathology fellowship training, along with the applicable medical education, licensure, and training-verification requirements. If you're still confirming whether you meet these prerequisites, our detailed breakdown at MGP Requirements 2026: Eligibility, Prerequisites & How to Qualify walks through each condition individually.
Building a Domain-Weighted Study Timeline
A generic study calendar wastes time if it treats every domain equally. Instead, allocate weeks in rough proportion to blueprint weight, front-loading the domains you're weakest in while they still have room to improve before test day. This is one of the few places a standard study framework - spaced repetition of high-yield facts combined with active recall on case material - actually maps cleanly onto MGP's structure.
Solid Tumors and Inherited Diseases
- Work through targeted therapy and companion diagnostic case sets
- Drill pedigree and inheritance-pattern problems until pattern recognition is automatic
Hematopathology, Molecular Genetic Principles, and Assay Validation
- Review recurrent translocations and WHO classification changes
- Practice assay validation scenarios: sensitivity, specificity, limit of detection
Quality, Infectious Disease, and Techniques/Methods
- Study QC/QA frameworks and proficiency testing rules
- Compare PCR, NGS, FISH, and Sanger sequencing use cases
Smaller Domains and Full-Length Practice
- Cover Pharmacogenetics, Identity Testing, Histocompatibility, and Informatics
- Run timed, full-length practice sessions replicating the six-section structure
If you want a condensed reference to keep in rotation during those final weeks, the MGP Cheat Sheet 2026: One-Page Review of Must-Know Facts is designed as a quick-recall companion rather than a primary study source. And for structured timed practice that mirrors the real exam's pacing across 245 questions, our practice test platform lets you simulate the six-section format before test day.
Understanding the Passing Standard and Recent Results
ABPath uses a scaled score of 500 as the passing standard for MGP - not a fixed raw percentage of correct answers. This means the difficulty of the specific question set you receive is factored into scoring, and you can't simply count how many items you think you missed to predict your outcome. For a deeper explanation of how scaled scoring works and what it means for your preparation, see MGP Passing Score 2026: Exactly What You Need to Pass.
In 2025, ABPath reported that 50 of 56 total examinees passed the MGP exam overall (89%), while 45 of 49 first-time examinees passed (92%). These numbers reflect candidates who met the eligibility bar and typically arrived with a full year of ACGME-accredited fellowship training - they are not a baseline you can expect without that preparation. For more context on how these figures compare across recent cycles, our dedicated article at MGP Pass Rate 2026: What the Data Shows breaks it down further. If you're trying to gauge overall exam difficulty before committing to a study plan, How Hard Is the MGP Exam? Complete Difficulty Guide 2026 puts the format, content breadth, and scoring standard into perspective.
Key Takeaway
A scaled score of 500 means consistent competency across domains matters more than acing a handful of favorite topics - spread your review across all 17 domains rather than over-preparing for just Solid Tumors and Inherited Diseases.
After You Pass: Maintaining Certification
Passing the initial exam is not the end of the obligation. ABPath certificates carry no fixed expiration date, but staying in good standing requires ongoing participation in Continuing Certification - biennial PATHway reporting, maintaining professional standing, and engaging in lifelong learning and practice improvement. The standard route requires 70 qualifying CME credits per two-year reporting period, with at least 80% of those credits related to your scope of practice; approved training and research alternatives exist for candidates outside a traditional CME pathway.
Many diplomates also participate in ABPath CertLink, a quarterly assessment model with a cumulative performance requirement of at least 60% averaged over four years. Note that these continuing-certification requirements apply specifically to ABPath diplomates; if your primary certification runs through ABMGG, you'll follow that board's own maintenance requirements instead. This distinction matters when planning your long-term certification calendar, especially if you hold certifications from both boards.
Common First-Attempt Mistakes to Avoid
- Underestimating the practical/written component. Candidates who study only multiple-choice question banks without practicing interpretation of sequence traces, karyotypes, and pedigrees are caught off guard by how embedded these materials are in actual items.
- Ignoring lower-weighted domains entirely. Histocompatibility (2%) and Identity Testing (4%) are small, but skipping them outright leaves easy points on the table across a 245-question exam.
- Confusing germline and somatic classification under time pressure. This distinction runs through Inherited Diseases, Inherited Cancer Syndromes, and Solid Tumors alike, and it's a common source of missed points.
- Not rehearsing the six-hour-plus testing day. With 6 hours 34 minutes of active testing inside a 9-hour-plus scheduled day, stamina and pacing matter as much as content knowledge.
- Waiting too long to confirm eligibility documentation. Training verification and primary certification status should be locked down well ahead of the application window, not sorted out at the last minute.
For candidates weighing whether the time, fee, and fellowship investment are worthwhile relative to career outcomes, Is the MGP Certification Worth It? Complete ROI Analysis 2026 and MGP Salary Guide 2026: Complete Earnings Analysis offer a broader look beyond exam-day preparation, while MGP Jobs covers the kinds of positions that value this subspecialty credential.
Frequently Asked Questions
No. Testing is administered in person at Pearson VUE Professional Centers; there is no remote or at-home proctoring option for this examination.
The 2026 schedule includes 245 questions across six sections, with 6 hours 34 minutes of active testing time within a scheduled day of roughly 9 hours 4 minutes.
ABPath uses a scaled passing score of 500 rather than a fixed raw percentage, so your result depends on scaled performance across the full question set.
Solid Tumors (11%), Inherited Diseases (10%), and Hematopathology (9%) carry the highest blueprint weights, but every domain contributes to your scaled score, so complete avoidance of smaller domains is risky.
ABPath certificates have no fixed expiration date, but ABPath diplomates must maintain standing through biennial PATHway reporting, 70 CME credits per two-year period, and participation options like ABPath CertLink.